Gerd Sutter - Infectious Diseases

Author Information

Gerd Sutter is a prominent researcher affiliated with the German Center for Infection Research (DZIF) and the Institute for Infectious Diseases and Zoonoses at LMU University of Munich in Munich, Germany. His research focuses on infectious diseases, with particular emphasis on vaccine development and viral immunology.

Research Contributions

Gerd Sutter has made significant contributions to the field of infectious diseases, particularly in the development of vaccines against emerging viral threats. His recent work includes research on vaccines for Ebola virus, Middle East respiratory syndrome (MERS), and SARS-CoV-2. Notably, his studies have explored the use of Modified Vaccinia Virus Ankara (MVA) as a vector for delivering antigens to induce protective immune responses. His research on intranasal delivery of vaccines and the impact of B cell depletion on T cell responses underscores his comprehensive approach to understanding immune mechanisms and improving vaccine efficacy.

Aliases

Gerd Sutter is also known by the aliases G Sutter and G. Sutter, which are used interchangeably in various academic publications.

Publication and Citation Metrics

Metric	Value
Total Citation Count	9213
h-index	51
Total Paper Count	212

Publications:

Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

DOI: 10.3390/vaccines10040533

Year: 2022

Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome

DOI: 10.1101/2022.02.14.22270168

Year: 2022

Activation of interferon regulatory factor 3 by replication-competent vaccinia viruses improves antitumor efficacy mediated by T cell responses

DOI: 10.1016/j.omto.2021.06.001

Year: 2021

Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement Home

DOI: 10.3201/eid2707.204670

Year: 2021

Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents

DOI: 10.3389/fimmu.2021.772240

Year: 2021

Circular Rep-Encoding Single-Stranded DNA Sequences in Milk from Water Buffaloes (Bubalus arnee f. bubalis)

DOI: 10.3390/v13061088

Year: 2021

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccination

DOI: 10.1101/2021.01.09.426032

Year: 2021

B cell depletion impairs vaccination-induced CD8+ T cell responses in a type I interferon-dependent manner

DOI: 10.1136/annrheumdis-2021-220435

Year: 2021

Discriminating the eight genotypes of the porcine circovirus type 2 with TaqMan-based real-time PCR

DOI: 10.1186/s12985-021-01541-z

Year: 2021

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

DOI: 10.1073/pnas.2026207118

Year: 2021

What are the recent advancements in RT-PCR?

How Can Surveillance Systems Be Improved?

How to Treat Rashes Caused by Infections?

Which Infections Are Most Affected?

What Types of Assays are Used in HTS for Infectious Diseases?

How is Rabies Diagnosed?

What are the Symptoms of Schistosomiasis?

What is One Health?

How Does a PCR Test Work?

Are Decongestants Safe?

Partnered Content Networks

Relevant Topics